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 The aspiration of oral and gastric substances is a well-known risk for ventilator 
associated pneumonia (VAP) in the intubated, mechanically ventilated (MV), patient of the 
intensive care unit (ICU) population. The gastric biomarker pepsin and the oral biomarker 
salivary amylase have been identified as evidence of aspiration prior to the manifestation of 
acute pulmonary illness. In an effort to decrease the risk for aspiration, several evidence based 
nursing practices are in place. Actions include 30 degree head of the bed positioning, oral care, 
suctioning, and circuit change interval protocols, as well as the administration of medication with 
the objective of reducing acid reflux. Additional recommendations concern the type of 
endotracheal tube (ETT) used to ventilate the intubated patient. The continuous subglottic 
suctioning endotracheal tube (CSS-ETT) features an additional port which continually suctions 
secretions that accumulate above the inflated endotracheal cuff. Patients with standard 
endotracheal tubes (S-ETT) receive manual, as needed suctioning of accumulated secretions in 
the mouth and the oropharynx per agency protocol. Research of the critical care population has 
demonstrated a decreased instance of VAP using CSS-ETT as compared to S-ETT utilization. 
This study sought to compare the incidence of the biomarkers pepsin and salivary amylase in the 
suctioned oral and tracheal secretions of patients with S-ETT compared to patients with CSS-
ETT. 
 Part of the protocol of a descriptive, comparative study of the clinical indicators for 
suctioning established the collection of the paired suctioned oral and tracheal aspirates. Those 
collected aspirates were analyzed for a pilot study of pepsin and amylase analysis. This study 
compares the incidence of aspirates in oral and tracheal secretions by endotracheal tube type. 
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 Tracheal aspirates were obtained with a closed tracheal suction device while oral 
secretions were obtained with a suction catheter designed to reach the oropharynx. Biomarkers 
assayed were the gastric marker pepsin and the oropharyngeal marker salivary amylase. Assays 
of pepsin and salivary amylase were performed using standard procedures in a specialty 
diagnostic laboratory. 
 Specimens were obtained from 11 subjects: 8 male and 3 female. The majority were 
Caucasian (n=9), had a CSS-ETT (n=8), were on mechanical ventilation in the synchronized 
intermittent mandatory ventilation mode, and on tube feedings (n=9) located in the stomach 
(n=7). The mean age was 56 years. Feeding tubes were placed in 9 patients, and the majority of 
the tubes were Dobbhoff. Pepsin was found in the oral secretions of 62.5% (n = 5) of the CSS-
ETT subjects, while 50.0% (n = 4) had pepsin in the tracheal aspirate. Pepsin was found in the 
oral secretions of 66.7% (n = 2) of the S-ETT subjects, and 66.7% (n = 2) had pepsin in their 
tracheal aspirate. All subjects of both groups (n = 11) had oral salivary amylase detected. 
Salivary amylase was detected in the tracheal aspirate of 100% (n = 3) of the S-ETT subjects 
versus 62.5% (n = 5) in CSS-ETT group.   
 Based on the results of this study, there was a reduction in the number of subjects who 
had oral compared to tracheal aspirate pepsin in the CSS-ETT group (n = 5 oral versus n = 4 
tracheal) tube type. The S-ETT group had equal number of subjects with oral (n = 2) and tracheal 
pepsin detected (n = 2). However, the results when comparing the S-ETT and the CSS-ETT 
groups were not statistically significant (p = 0.898 pepsin oral and 0.621 tracheal pepsin).  
 There may be clinical significance. It appears that the CSS-ETT was beneficial in that 
group; two fewer subjects had pepsin in their tracheal aspirate (n = 5 oral versus n = 4 tracheal 
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aspirate pepsin). The intention of this study was that it would assist in demonstrating beneficial 
aspects of the selection of the CSS-ETT. It is considered that further investigation with a larger 
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Terms and Definitions 
 
Terms Operational and Conceptual Definitions 
amylase 
an enzyme that splits starch; amylase in humans is 
distinguished by salivary or pancreatic type 
aspiration  
 
entry of gastric or oropharyngeal secretions due to absence 
of protective mechanisms (i.e. when intubated) 
biomarker 
a biochemical or molecular indicator used to screen for 
disease 
CSS-ETT 
continuous subglottic suctioning endotracheal tube; 
double lumen tube featuring a separate dorsal lumen 
allowing accumulated secretions from above the tracheal 
cuff to be removed continually through holes 
early onset pneumonia pneumonia that occurs prior to day five of hospitalization 
ETCO2   
end tidal carbon dioxide; an indicator of pulmonary 
ventilation  
ETT endotracheal tube 
gastric reflux 
regurgitation from stomach into the upper gastrointestinal 
tract 
ICU intensive care unit in a hospital 
late onset pneumonia 
pneumonia that occurs after day five of hospitalization; 
frequently associated with drug resistant organisms 
LOS length of stay 
microaspiration 
aspiration of oropharyngeal and gastric secretions into the 
airways of intubated and mechanically ventilated patients 
MV mechanical ventilation 
oropharyngeal 
the part of the pharynx between the soft palate and the 
upper edge of the epiglottis 
pepsin the chief gastric enzyme used to break down proteins 
S-ETT 
standard endotracheal tube; endotracheal tube comprised 
of a central lumen with an inflatable cuff  
SIMV 
Synchronized Intermittent Mandatory Ventilation; periodic 
assisted mechanical ventilation synchronized with the 
patient's breathing which maintains a preset rate if the 
patient fails to self-ventilate 
sputum 
a respiratory tract specimen of mucus obtained with 
suction and collected in an inline trap 
tracheal 
pertaining to the trachea which carries air from neck 
through upper chest 
tracheal aspirates 
secretions removed from the trachea by suctioning that 
area 
ventilator-associated pneumonia pneumonia that occurs after endotracheal intubation 
ventilator days used by agencies to compare incidence of VAP 
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CHAPTER 1: INTRODUCTION 
Background 
Need for Mechanical Ventilation 
 If deemed medically necessary to support adequate oxygenation and tissue perfusion, 
critically ill patients are intubated and mechanically ventilated. Airway patency is maintained via 
an artificial airway while the work of ventilation can be regulated by a mechanical source when 
the patient is unable to execute this effort naturally. One type of artificial respiration is delivered 
through an endotracheal tube which passes into the patient’s mouth, past the oropharyngeal area, 
through the epiglottis into the trachea where an inflated cuff creates positive pressure for 
ventilation and secretions often pool above the cuff. The semi rigid endotracheal tube is made of 
a plastic, polymer type material and has been tested to conform to established specifications 
regarding size and performance (Simmons & Scanlon, 2009). The patient ventilation circuit 
connects the mechanical ventilation source to an endotracheal tube providing pathways for 
inspiration and expiration. 
Inflatable Cuff 
 Endotracheal tubes create an open airway through the patient’s mouth and oropharyngeal 
area to the trachea where the tube is held in place by an inflatable cuff.  The cuff of the 
endotracheal tube serves to seal the space between the central lumen and the walls of the trachea 
which allows proper lung expansion by positive pressure inflation of the patient’s lungs when 
using mechanical ventilation.  The inflated cuff also helps to prevent aspiration of secretions that 
without a barrier could enter the lower part of the respiratory tract (Pierce & Sole, 2009). 
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However, the cuff does not form a perfect seal in the trachea, and upper airway, pooled, and 
collected substances are aspirated into the patient’s lower airway.  
Risk for Aspiration 
 Life sustaining mechanical ventilation and endotracheal tubes pose inherent risks, such as 
risk for microaspiration into the lower airway of substances accumulated in the upper airway.  
Mechanically ventilated patients often experience gastric reflux which is the reverse flow of 
gastrointestinal substances into the oropharyngeal area. Oral or gastric secretions are normally 
cleared by coughing or expectorating. However, in the mechanically ventilated patient, 
substances often accumulate subglottically above the inflated cuff of endotracheal tubes.  The 
cuff does not form a perfect seal; microaspirates such as oropharyngeal secretions and substances 
of gastric origin enter the trachea from above the cuff and can seep into the lower airway via 
leaks and folds (Nseir, Zerimech, Jaillette, Artru, & Balduyck, 2011).   
Statement of the Problem 
Maintain Patent Airway 
 Critically ill patients undergoing mechanical ventilation with an endotracheal tube are 
unable to effectively clear their airway of accumulated oral secretions or gastrointestinal 
substances. Secretions typically consist of the patient’s oropharyngeal endogenous mucus and 
microbes, but may also contain gastric enzymes or substances, and these potential aspirates are a 
well-known risk for ventilator-associated pneumonia (Bouza et al., 2008; Pierce & Sole, 2009).  
Respiratory therapists and nurses clear airway secretions by using negative pressure to suction 
the fluids through a catheter which empties the contents into a collection container.  This is 
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accomplished in order to prevent aspiration of the secretions, maintain the airway, and reduce the 
risk of ventilator-associated pneumonia.    
Pooling Secretions 
 Nurses or respiratory therapists suction the central lumen of endotracheal tubes on an as 
needed basis and per agency schedule to clear tracheal secretions.  A specialized tube known as 
the continuous subglottic suctioning endotracheal tube (CSS-ETT) contains an additional dorsal 
lumen that allows constant or intermittent removal of the contents that pool above the cuff. The 
standard endotracheal tube (S-ETT) consists of a single, central lumen. Research has shown that 
the risk for aspiration of the pooled, accumulated secretions, which creates a risk for ventilator-
associated pneumonia, is greater for patients with the S-ETT (Bouza et al., 2008).  
Professional and Agency Recommended 
 According to the Institute for Healthcare Improvement (IHI), ventilator-associated 
pneumonia increases the number of days spent on the mechanical ventilator, increases the length 
of stay in the hospital, costs an additional $40,000, and ranks highest in number of deaths from 
hospital-acquired infections (2011, n.p.).  Use of the CSS-ETT has shown a 52% decrease in the 
incidence of ventilator-associated pneumonia, shorter patient hospital stays, and, additionally, 
patients were extubated and moved out of the intensive care unit sooner than when compared to 
the S-ETT data (Leasure, Stirlen, & Lu, 2012).  The American Association of Critical Care 
Nurses (AACN) includes the recommendation of using a CSS-ETT in a ventilator-associated 
pneumonia practice alert (2008). Moreover, recommendations from the Centers for Disease 
Control (CDC) included the use of the CSS-ETT (Tablan, Anderson, Besser, Bridges, & Hajjeh, 




 Nurses are responsible for ameliorating the risk of aspiration in the mechanically 
ventilated patient and frequently assess the patient for signs that suctioning of secretions is 
needed in order to maintain a clear airway (Pierce & Sole, 2009). Since the two types of 
endotracheal tubes are in use in the clinical setting, there may be differences in the incidence of 
aspirates when comparing S-ETT and CSS-ETT suctioned secretions. When analyzed, the data 
may indicate an additional or amended nursing intervention recommendation. Some current 
nursing interventions include maintaining a 30 degree head of the bed positioning, completing an 
auscultation assessment for suctioning need, providing regular oral care, and ensuring that any 
pooled secretions are removed prior to balloon deflation when extubating the patient from the 
endotracheal tube (Pierce & Sole, 2009).   
Purpose of the Study 
 This study compared the incidence of pepsin and amylase which was collected via the 
routine oropharyngeal and tracheal suctioning of critical care patients mechanically ventilated 
with either S-ETT or CSS-ETT. Suctioned specimens collected were analyzed to compare the 
incidence of pepsin and salivary amylase in oral and sputum samples by tube type. Based on the 
results of this study, more insight may be gained in order to guide future nursing actions. 
Additionally, based on the incidence of aspirate analysis, additional support of the 
recommendation which advocates the use of the CSS-ETT could be demonstrated (AACN, 
2008).  The overarching goal is the prevention of ventilator-associated pneumonia by meeting 
the objective of decreased risk for aspiration as indicated by a reduced incidence of designated 




 The hypothesis of this study is that there will be a difference in the incidence of pepsin 
and amylase in the oral and tracheal aspirate by endotracheal tube types. It is anticipated that due 
to the subglottic suctioning feature of the CSS-ETT, a reduced incidence of pepsin and amylase 
will be recorded. 
Research Question 
 Will there be a difference in the incidence of pepsin and amylase when comparing by the 
endotracheal tube type? 
Summary 
 To support adequate oxygenation and tissue perfusion, critically ill patients are intubated 
and mechanically ventilated via an endotracheal tube forming the artificial airway. The 
endotracheal tube’s inflatable cuff serves to seal the space between the wall of the tube and the 
trachea. The patient is unable to effectively cough and expectorate because the epiglottis is kept 
open by the tube passing through into the trachea. Gastric reflux or oral secretions tend to pool 
above the inflated cuff of endotracheal tubes. These pooled substances are potential aspirates and 
are a well-known risk for ventilator-associated pneumonia. Research has shown that the risk for 
aspiration is greater for patients with the S-ETT. Governmental agencies and professional 
organizations have recommended the use of the CSS-ETT. Even so, Krein et al. (2008) found in 
a nationwide survey of more than 500 hospital infection control professionals, only 21% reported 
using subglottic suctioning tubes. This study may add to the body of knowledge related to the 




CHAPTER 2: REVIEW OF LITERATURE 
Literature Search 
 A literature search was performed in using the Cumulative Index to Nursing and Allied 
Health Literature (CINAHL) and MEDLINE databases. The date range was 2002 to 2012.  The 
goal of the literature searches was to locate studies comparing incidence of aspiration by 
endotracheal tube types with the biomarkers salivary amylase and pepsin identified. The 
overarching goal in identifying markers of aspiration in the mechanically ventilated patient is to 
prevent disease, so a key word for the respiratory disease was included. The following terms 
were used: aspiration, ventilator-associated pneumonia, subglottic suctioning, endotracheal tube 
type, pepsin, and amylase. The searches were performed in combinations and yielded no results 
that studied pepsin or amylase as biomarkers for aspiration and comparing endotracheal tube 
types. It should be noted that aspiration in this context signifies microaspiration into respiratory 
tract of exogenous substances such as gastric or oropharyngeal substances. 
Subglottic Suctioning and Decreasing the Risk for Aspiration 
 Pepsin and salivary amylase can be detected in tracheal aspirate specimens in laboratory 
settings, are indicators of aspiration, and as such their incidence can be useful when comparing 
tube types in an effort to prevent ventilator-associated pneumonia. One study discussed the silent 
aspect of aspiration, the damage that can rapidly occur to lung tissue, and that more detection 
efforts are warranted in order to prevent complications. Nseir, Zerimech, Jaillette, Artru, and 
Balduyck (2011) reviewed numerous interventions currently in practice such as patient 
positioning, maintenance of cuff pressure, feeding tube function surveillance, and different 
designs of endotracheal tubes. Subglottic suctioning tubes show promise in removing the 
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potential aspirates regurgitated from the gastrointestinal tract or other secretions that emanated 
from the oropharyngeal region. Subglottic suctioning tubes remove potential oral or gastric 
substances that have accumulated above the cuff of the endotracheal tube through an additional 
dorsal lumen. The conventional or standard tube features a central lumen which is suctioned 
distally from the inflated cuff. Aspiration of the accumulated secretions which pool around the 
cuff of the S-ETT is a well-known risk factor for ventilator-associated pneumonia. This study 
compared the standard versus continuously suctioning subglottic endotracheal tubes and the 
incidence of pepsin and amylase as biomarkers of aspiration. No studies were located during the 
review of literature that compared endotracheal tube type and marker of aspiration incidence.  
A diagram of a subglottic suctioning endotracheal tube (CSS-ETT) is shown below. The black 
line represents the additional, dorsal lumen tube that removes pooled secretions above the cuff 
from the subglottic space. The standard endotracheal tube (S-ETT) features a single, central 
lumen with no subglottic suction lumen. 
 






subglottic area in red 
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Lowering the Incidence of Ventilator-Associated Pneumonia 
 The search for a comparison of endotracheal tube types produced results which were 
retained if the study compared standard to subglottic suctioning tube types or focused on the 
prevention of aspirates entering the lower airways as a risk for ventilator-associated pneumonia 
by using subglottic suctioning tubes. Ten articles include original research in the form of 
retrospective records reviews (n = 2) or randomized clinical controlled trials (n = 4) and 
systematic, meta-analysis reviews (n = 4). Taking the four meta-analyses as a unit, the findings 
of 16 total, not duplicated studies are detailed. The publication dates of the articles range from 
1995 to 2010. The studies present data gathered during the hospitalization of 3,032 intubated, 
mechanically ventilated, critical care patients in the United States, Europe, China, and India. The 
subglottic suctioning groups from the original research studies utilized either intermittent (n = 4) 
or continuous (n = 2) subglottic suctioning. The meta-analyses incorporated both intermittent and 
continuous subglottic suctioning methods in their reviews. Antibiotic use, nosocomial infections, 
and cost analysis were measured in some studies. Other secondary outcome measures in the 
majority of studies were days to ventilator-associated pneumonia onset, duration of mechanical 
ventilation, length of ICU and hospital stay, and mortality. However, overall, the primary 
objective of the included studies was a comparison of standard endotracheal tubes to subglottic 
suctioning tubes and quantification of the incidence of ventilator-associated pneumonia.    
Major Heart Surgery Patients and Lower VAP Rate with CSS-ETT 
 Bouza et al. (2008) studied of rate of ventilator-associated pneumonia by tube type.  In 
this prospective, randomized study of 714 major heart surgery patients in Spain, at induction of 
anesthesia, patients were assigned to either the standard or continuous aspiration of subglottic 
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secretions group (CSS-ETT). The CSS-ETT group experienced lower rates of ventilator-
associated pneumonia, shorter duration of mechanical ventilation, fewer days in the length of 
stay in the intensive care unit and the hospital, lower rates of antibiotic use, and fewer 
nosocomial infections. Mortality rates were similar with the standard group (n = 21) and the 
CSS-ETT group (n = 20).  
Mean Hospital Charges Less for CSS-ETT Group 
 Speroni et al. (2011) compared the two tube types utilizing the continuous suctioning 
subglottic device. In this retrospective records review, 154 adult intensive care unit patients were 
intubated with either standard (n = 77) or continuous subglottic suctioning (n = 77) tubes. The 
primary outcome measure was the cost in total hospital charges for the patient based on tube 
type, if there was a ventilator-associated pneumonia diagnosis during the hospital stay, and if the 
two costs offset each other.  The mean charges were $103,600 for the S-ETT group and one 
ventilator-associated pneumonia diagnosis was made. None of the CSS-ETT patients were 
diagnosed with ventilator-associated pneumonia and the mean charges were $88,500. The 
number of intensive care unit and mechanical ventilation days was greater for the CSS-ETT 
group, but one ventilator-associated pneumonia incident in the standard group incurred 
additional cost making the CSS-ETT more cost effective. Speroni et al. (2011) offered an 
explanation for the greater ICU and MV days in the CSS-ETT groups compared to the S-ETT 
groups. The patients with CSS-ETT were forecasted at the time of intubation to require more 
MV support days than the patients with S-ETT. Another study has found that physicians are 60-
80% accurate in determining a need for prolonged mechanical ventilation at the time of 
intubation (Dezfulian et al., 2005). 
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Reduction in VAP Rate per 1,000 Ventilator Days 
 In 2011, Junega et al. reviewed the records to compare standard and intermittent 
subglottic suctioning endotracheal tubes to incidence of ventilator-associated pneumonia per 
1,000 ventilator days during a three year period on an eight bed medical intensive care unit in 
India. The incidence of ventilator-associated pneumonia was 15.7 episodes per 1,000 ventilator 
days with a closed system, intermittent subglottic suctioning group to 25 episodes of VAP per 
1,000 ventilator days with an open system, standard endotracheal tube control. No other results 
were deemed significant by the researcher. 
Lower Rates of Early and Late Onset VAP 
 In a 24 bed medical-surgical intensive care unit in Spain, 280 patients assessed to require 
more than 24 hours mechanical ventilation were randomly assigned to intubation with either a 
standard or intermittent subglottic suctioning endotracheal tube. Lorente, Lecuona, Jiménez, 
Mora, and Sierra (2007) compared the incidence of ventilator-associated pneumonia and the days 
to onset. The control group experienced higher rates of ventilator-associated pneumonia (22.1%) 
versus the subglottic drainage group (7.9%). Rates of early and late ventilator-associated 
pneumonia onset were also lower in the subglottic secretion drainage group.  
 Lacherade et al. (2010) randomly assigned patients requiring more than 48 hours of 
mechanical ventilation to either standard or subglottic suctioning endotracheal tube intubation at 
four intensive care units in France. The results of this multicenter study of 333 subjects revealed 
that patients with the subglottic secretion drainage had lower rates of ventilator-associated 
pneumonia (14.8% vs. 25.6%), lower rates of early onset ventilator-associated pneumonia (1.2% 
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vs. 6.1%), and late onset ventilator-associated pneumonia (18.6% vs. 33.0%). Neither hospital 
mortality nor duration of mechanical ventilation results was significant between the two groups. 
Incidence of VAP Reduced in CSS-ETT Group 
 In 2002, Smulders et al. randomly assigned 150 adult intensive care unit patients in the 
Netherlands expected to receive mechanical ventilation for longer than 72 hours to be intubated 
with either standard or subglottic suctioning tubes. The primary objective determining incidence 
of ventilator-associated pneumonia demonstrated a rate of 16% in the standard group and 4% in 
the subglottic drainage group. The other outcome measures of duration of days on mechanical 
ventilation, length of intensive care unit and hospital stay and mortality were not significant in 
the study. 
Dezfulian et al.’s Meta-Analysis of 16 Randomized Clinical Trials 
 The four meta-analyses reviewed 16 randomized clinical trials that compared standard 
endotracheal tubes to either intermittent or continuous suctioning subglottic endotracheal tubes. 
Dezfulian et al. (2005) selected five studies comprising 896 patients four of which were targeted 
at patients expected to receive mechanical ventilation for greater than 72 hours. The fifth study 
concerned patients undergoing cardiothoracic surgery with a mean mechanical ventilation time 
of 1.5 days. The five sites included three medical-surgical intensive care units, one 
cardiothoracic intensive care unit, and one surgical intensive care unit. Other interventions to 
prevent the occurrence of VAP were included by the researchers. All studies included medication 
selected for stress ulcer prophylaxis and the use of antibiotics as well. Endotracheal cuff pressure 
checks were assessed at four or eight hour intervals in three studies. One study included head of 
the bed elevation protocols and a minimization of mechanical ventilation circuit changes. The 
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methods of subglottic drainage varied among the studies. Two studies utilized continuous wall 
suction, two studies utilized intermittent wall suctioning, one low intermittent, one high 
intermittent, and the fifth study removed subglottic secretions with a syringe on an hourly 
interval.  Secondary outcome measures were early onset VAP, late onset VAP days on 
mechanical ventilation, length of stay in the ICU, and mortality. Early onset VAP is pneumonia 
occurring by day five after intubation. Late onset VAP occurs on day five or later. One of the 
five studies was excluded after the data were analyzed and it was found to be contrary to the 
other four. It was determined that this was due to the fact the excluded study concerned 
postoperative patients anticipated to require mechanical ventilation less than two days for whom 
the review concludes that subglottic suctioning is not beneficial as with longer intubations. 
 Dezfulian et al. (2005) reported that the frequency of ventilator associated pneumonia 
was decreased by almost 50%, and early onset VAP and the number of days on MV and ICU 
LOS were also decreased in the subglottic suctioning group compared to the standard 
endotracheal tube type group. There were also increased number of days to diagnosis of VAP in 
the subglottic drainage group, but there was no significant effect on mortality between the 
groups. The benefit of the subglottic suctioning tube is greatest realized by the patients MV for 
greater than 72 hours and in this meta-analysis, prevention of early onset of pneumonia is the 
most significant contribution. Dezfulian et al. (2005) suggests that late onset pneumonia may be 
due to other factors such as adherence of bacteria to the endotracheal tubes via the formation of 
biofilm. Subglottic suctioning would have no effect in the removal of that type of threat since the 
area of entry is the central lumen of the endotracheal tube. The cost savings comparing the 
higher cost of the subglottic suctioning tube to the cost of one VAP diagnosis amounted to 
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$3,535 according to the researchers’ calculations. Dezfulian et al. (2005) additionally concluded 
that physicians are 60-80% accurate in determining at time of intubation a need for prolonged 
mechanical ventilation. As the review surveyed three different types of intensive care units 
(cardiothoracic, surgical and medical-surgical) the results obtained are generalizable to different 
settings. This meta-analysis concludes that the most benefit is realized by those receiving greater 
than 72 hours of mechanical ventilation where two day shorter mechanical ventilation and a three 
day shorter ICU stay were demonstrated. Dezfulian et al. (2005) offers that tube type selection 
could be made with consideration of which group of patients most benefit from the subglottic 
suctioning option during their hospital stay.  
Muscedere et al.’s Meta-Analysis of 13 Randomized Clinical Trials 
 In 2011, Muscedere et al. published a meta-analysis of 13 randomized controlled studies 
reporting the incidence of VAP as the primary outcome. Adult ICU patients were initially 
intubated with either S-ETT in the control group or CSS-ETT in the experimental group. The 
studies differed in the expected mechanical ventilation requirements at the time of intubation. 
The anticipated time frames ranged from greater than 24 hours to greater than five days 
mechanical ventilation.  Secondary outcomes measured by the studies and analyzed by the 
reviewers included length of stay in the ICU and in the hospital, duration of MV, onset of VAP, 
the use of antibiotics, and mortality. In all of the studies, VAP was diagnosed radiographically; 
however, some studies included bronchoalveolar lavage quantification or endotracheal aspirate 
cultures. It should also be noted that three studies did not require an additional microbiological 
confirmation for the diagnosis of VAP. Twelve of the thirteen studies reported reduced rates of 
VAP with the use of a CSS-ETT. Reduction of VAP was similar between the intermittent and 
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continuous suctioning methodology compared to the standard tube type. Dezfulian et al (2005) 
had also concluded it their study that subglottic secretion removal was the key determinant in 
prevention of VAP. Overall, the CSS-ETT group experienced an ICU stay of 1.52 fewer days, 
MV was reduced by 1.08 days, and the onset of VAP was delayed by 2.66 days compared to the 
standard group. Neither hospital length of stay nor mortality was affected. The potential cost 
avoidance benefit calculating the low cost of the subglottic suctioning tube versus the higher cost 
of one occurrence of VAP was stressed by the reviewer. The issue of determining which patient 
should be intubated by which tube type was discussed as well. It was suggested that all patients 
in either an emergency situation or forecasted to require postoperative MV should be intubated 
with a subglottic suctioning tube. There was discussion regarding the practice of changing from a 
standard to a subglottic suctioning tube in an effort to reduce VAP risk. More research is 
required examining the benefit of reducing VAP risk versus the repeated intubation and the 
potential complications therewith. Muscedere et al. (2011) suggests further research is required 
in how to increase the use of CSS-ETT into practice given the evidentiary benefits. 
Leasure et al.’s Meta-Analysis: Mortality not Affected by Tube Type 
 Leasure et al. (2012) reviewed 12 out of the 13 random clinical trials that Muscedere et 
al. (2011) analyzed and four of the five that Dezfulian et al. (2005) had reviewed. The primary 
outcome measured was incidence of VAP comparing standard versus subglottic suctioning 
endotracheal tubes, and the secondary outcomes were days to ventilator-associated pneumonia 
onset, duration of mechanical ventilation, and length of ICU and hospital stay. Again, a 50% 
decrease in ventilator-associated pneumonia rates was assessed in the experimental group, 
shorter ICU stays, and fewer days with mechanical ventilation which is equivalent to what had 
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been noted in the previous two meta-analyses. Leasure et al. (2012) suggests that additional 
research focus on one interventional change in studies in order to clarify that the improvements 
were directly attributable to that intervention. As also seen in Muscedere et al. (2011) and 
Dezfulian et al. (2005), mortality was not affected by tube type, and Leasure et al. (2012) 
suggests that mortality may be more attached to the overall poor condition of the patient rather 
than tube type. In other words, consistently, tube type has been shown to be inconsequential to 
mortality.    
Wang et al.’s CSS-ETT Future Research Suggested  
 The reviewer of the fourth meta-analysis compared standard versus subglottic suctioning 
endotracheal tubes from 10 randomized controlled trials, five of which postdated Dezfulian et 
al.’s work in 2005. These results were compared to primarily focus on incidence of VAP and 
secondarily to days to onset, duration of mechanical ventilation, length of ICU and hospital stay, 
and mortality (Wang et al., 2012). Consistent with the previous meta-analyses discussed, VAP 
incidence was decreased in the subglottic suctioning group, early onset VAP was decreased, days 
to onset were increased, and mechanical ventilation days were decreased. No significant 
differences were found related to mortality, late onset VAP, length of stay in the ICU or in the 
hospital overall. Wang et al. (2012) separated the intermittent and continuous suctioning patients 
into a sub group and after analysis discovered that the VAP rates for each were again similar as 
found in Dezfulian et al.’s (2005) study. Also similar to the other three meta-analyses were the 
findings that there was no effect on mortality, late onset VAP, or duration of ICU or hospital 
stay. Wang et al.’s (2012) meta-analysis raises the issue of  the safety of subglottic suctioning in 
light of concerns regarding post extubation laryngeal edema and animal study tracheal injury. 
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Additionally, future research investigating the prevention of late onset VAP is warranted in order 
to fully evaluate the findings by Lacherade et al. (2010) and Lorente et al. (2007) which were not 
observed in any of the meta-analyses.     
Summary 
 The mechanically ventilated, intensive care unit patient is at risk for development of VAP 
for several reasons. Interventions are in place to decrease the risk for this life threatening 
complication. Researchers have investigated many variables such as head of the bed positioning, 
maintenance of cuff pressure, prophylactic use of antibiotics and gastric reflux inhibitors, and 
endotracheal tube type with mode of subglottic suctioning, intermittent or continuous. Reduction 
of VAP was similar between the intermittent and continuous suctioning methodology. Two 
researchers found decreased rates of late onset VAP comparing the tube types which was 
contrary to the results of the other studies. This is possibly due to the larger sample size revealing 
the late onset benefit which was absent in other smaller studies (Lacherade et al., 2010). The 
accumulation of biofilm has been postulated as the cause of the development of late onset VAP.  
 The literature review confirms that there is a distinct difference in the rate of VAP 
between the standard versus subglottic suctioning groups. Consistently, there was about a 50% 
decrease in the incidence. Furthermore, the cost of the subglottic tubes is offset by the finding 
that of every 100 patients intubated with a subglottic suctioning endotracheal tube, 11 cases of 
VAP are avoided (Lacherade et al., 2010).  
 Biomarkers may be used as proof of silent microaspiration delivering data clinicians can 
use to implement additional VAP precautions. Detection of substances exogenous to the lower 
respiratory tract provides information that may be useful in order to prevent VAP from occurring 
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(Nseir, 2011).  At least, the selection of the CSS-ETT may prolong the number of days to VAP 
onset which could buy time for recovery and an opportunity for extubation.   
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CHAPTER 3: METHODS AND PROCEDURES 
Design 
 This study was a secondary, retrospective review of data collected during a descriptive, 
comparative study examining the clinical cues for ETT suctioning. 
Subjects 
 The 11 subjects for this study were critically ill patients intubated with either a CSS-ETT 
or S-ETT and receiving MV. All subjects were also participants in the primary suctioning cues 
study (Sole & Bennett, 2012).  
Inclusion Criteria 
 The inclusion criteria for this secondary study were adult, critical care patients who met 
the requirements of the primary study for periodic suctioning by a closed system and that 
traditional mechanical ventilation was provided through an ETT.  
Exclusion Criteria 
 This study excluded participants of the primary study if mechanical ventilation was 
provided via tracheostomy. Study participants were excluded if endotracheal suctioning was 
contraindicated on the patient’s medical record, suctioning was performed by open method, non-
traditional ventilation modes were in use, or if they were already enrolled in another research 
study.  
Sample Size Determinants 
 The sample size was determined by the number of subjects who met the criteria and 
consented to participate from June 1, 2012 through August 31, 2012. During that time, 11 




 The independent variable was tube type, CSS-ETT or S-ETT, and the dependent 
variables were presence of pepsin or salivary amylase in oral or tracheal suctioned secretions. 
Procedures 
Demographic Data 
 Demographic data were obtained including diagnoses, type of airway, presence of a 
feeding tube and placement location, duration of intubation and MV, Glasgow Coma Scale, type 
of mechanical ventilation supplied, age, gender, and ethnicity. Characteristics are shown in  
Table 1. 
Specimen Collection 
 The research protocol included paired sampling of oral and tracheal specimens. While an 
oral secretion sample was obtained using a deep suctioning catheter, an endotracheal aspirate 
was also obtained. A baseline suctioning event (with paired specimen collection) marked the 
beginning of the study. The study endpoint was the completion of one to four hours of 
assessment data. The study participants were assessed every hour for up to four hours for ETT 
suctioning need based on clinical indicators such as ventilator waveform, coarse crackles 
auscultated over the trachea, inability of the patient to generate an effective cough, deteriorating 
oxygen saturation values, visible secretions in the airway, or signs of respiratory distress. Closed 
tracheal suction system was used for tracheal specimen collection. The patients were 
hyperoxygenated prior to suctioning with the suction pass lasting 15 seconds or less. The number 
of passes was recorded as to how many it took to clear the airway of secretions. Tracheal 
secretions were collected into a specimen trap.  Five (5) mL of normal saline for respiratory use 
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cleared the suction catheter after every suctioning event. Following the tracheal suction, the 
mouth was suctioned with a deep suction catheter and the secretions were collected in the 
sputum trap.  
Tracheal aspirate volume was measured by the graduated markings on the aspirate trap, 
less any saline volume that had been instilled. The aspirate traps were weighed after the suction 
event with the weight of the trap and saline subtracted in order to arrive at a net aspirate weight 
for that suctioning event. Posts suctioning physiological data were recorded. ETCO2 waveform 
tracings and digital photographs of the ventilator waveform were taken post suctioning. The 
assessments were repeated every hour up to four hours. The study period ended after four hours 
post initial suction event or after completion of one additional ETT suctioning event, whichever 
came first. If assessment indicated that there was no need for suctioning, after four hours the 
patient was suctioned per protocol.  
Biomarkers 
 By suctioning the oral cavity as well as the airway in a paired manner, biomarkers in the 
collected secretions were assessed for origin. Salivary amylase is oropharyngeal in origin while 
pepsin is endogenous to the stomach. Established enzymatic assay procedures for the detection 
of biomarkers of aspiration, pepsin and salivary amylase, were utilized (Appendix E). Pepsin was 
determined by measuring total pepsin.  
 In order to quantify salivary amylase present in the specimen samples, substrate was 
added to tint the end product of the samples through a process of metabolic breakdown. The rate 
of absorbance was calculated at 405 nm proportional to the activity of total amylase in the 
sample. Then, acarbose was used to inhibit salivary amylase in the sample; and the remaining 
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activity was pancreatic amylase activity only. The amount of salivary amylase was derived by 
subtracting the pancreatic activity from the total amylase activity in the specimen.  
Endotracheal Tubes 
 Patient demographic data included the ETT type (Table 2). Oropharyngeal and tracheal 
aspirate specimens were collected, measured, recorded, and analyzed from each tube type in the 
same manner.  
Handling of Specimens 
 All specimens were placed in a biohazard bag and kept chilled on ice. The specimens 
were transported by one of the primary study investigators to the agency research laboratory at 
the completion of data collection.  
Maintaining Confidentiality 
 No patient identifying information or images were recorded. All oral or tracheal aspirate 
sample specimens were labeled with unique identifying numbers without any HIPAA identifiers.  
Informed Consent 
 The research study was explained to persons with the authorization for the healthcare 
consent each participant. Informed consents were obtained for all subjects.   
Data Analysis 
 Statistical Package for the Social Sciences (SPSS) version 19.0 was used for data 
analysis. Demographic data were summarized with frequencies and descriptive statistics. 
Descriptive, quantitative analysis assessed the collected oropharyngeal and tracheal suctioned 
secretions of patients comparing each by tube type for the presence of pepsin and amylase using 
the cross tabulation procedure. 
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CHAPTER 4: FINDINGS 
Hypothesis 
 The hypothesis of this study is that there will be a difference in the incidence of pepsin 
and amylase in the oral and tracheal aspirate by endotracheal tube types. It is anticipated that due 
to the subglottic suctioning feature of the CSS-ETT, a reduced incidence of pepsin and amylase 
will be recorded. 
Research Question 
 Will there be a difference in the incidence of pepsin and amylase when comparing by the 
endotracheal tube type? 
Results 
Study group demographics 
 Pepsin and amylase assays were performed on oropharyngeal and tracheal samples from 
11 subjects ranging from 19 to 91 years old with the median age 62. This subgroup of the 
primary suctioning cues study were mostly male (n =8), non-Hispanic (n = 9), and were on tube 
feeds (n = 9). The majority of the tube feeds were Dobbhoff (n =5) ending in the stomach (n = 
7). Most of the subjects were mechanically ventilated with a CSS-ETT (n = 8) with the majority 
operating in SIMV mode (n = 9). The Glasgow Coma Scale median value was 10.0. The median 
value for endotracheal intubation and mechanical ventilation was 5.5 days, and ranged from one 




Table 1: Demographic Characteristics of Sample: Frequencies and Median  
 
Demographic  Participants (n =11) 
Gender 8 male 
3 female 
  
Age 62.0 years  
  
Ethnicity 9 Non-Hispanic 
2 Hispanic 
  
Type of ETT 3 Standard 
8 Subglottic 
  
ETT Size 7.5 
  
Duration ETT 5.5 days 
Duration MV 5.5 days 
  










Tube Placement 7 stomach 
3 post-pyloric 
1 no tube 
  
Laboratory Analysis of Amylase and Pepsin Specimens 
 Paired oropharyngeal and tracheal aspirate specimens were collected during the same 
suctioning event. The sample volumes were recorded, and analyzed from each of the 11 subjects 
in this study. The incidence of amylase in the oral and tracheal samples by tube type is reported 
in Table 2.  
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Table 2: Salivary Amylase Incidence by Sample Location and Type of ETT 
Endotracheal Tube 
Type 
Amylase Oral Detected Amylase Tracheal Detected 
S-ETT (n = 3) Yes = 3 (100%) Yes = 3 (100%) 
No = N/A No = N/A 
CSS-ETT (n = 8) Yes = 8 (100%) Yes = 5 (62.5%) 
No = N/A No = 3 (37.5%) 
p value oral amylase constant 0.214 
Oral = oropharyngeal samples; Tracheal = tracheal aspirate sample 
 
 In the S-ETT group, amylase was detected in 100% of the subjects oropharyngeal 
samples while amylase was detected in 100% of the subjects’ the tracheal aspirate sample as 
well. In the CSS-ETT group, amylase was also detected in 100% of the subjects’ oropharyngeal 
samples. The tracheal aspirate sample had amylase detected in 62.5% in the CSS-ETT subjects 




 The incidence of pepsin in the oral and tracheal aspirate samples is reported on Table 3.  
Table 3: Pepsin Incidence by Sample Location and Type of ETT 
Endotracheal Tube 
Type 
Pepsin Oral Detected Pepsin Tracheal Detected 
S-ETT (n = 3) Yes = 2 (66.7%) Yes = 2 (66.7%) 
No = 1 (33.3%) No = 1 (33.3%) 
CSS-ETT (n = 8) Yes = 5 (62.5%) Yes = 4 (50.0%) 
No = 3 (37.5%) No = 4 (50.0%) 
p value 0.898 0.621 
Oral = oropharyngeal samples; Tracheal = tracheal aspirate sample 
 
 Comparing the incidence between the tube type groups, 66.7% of the S-ETT group (n = 
2) had pepsin detected in oropharyngeal samples versus 62.5% of the CSS-ETT group (n = 5). 
Pepsin was detected in the tracheal aspirate samples of 50.0% of the CSS-ETT group (n = 4) and 
66.7% of the S-ETT group (n = 2).  
 The 11 subjects can be viewed according to their endotracheal tube type, day of 
mechanical ventilation with an endotracheal tube, cuff pressure, feeding tube type and 
placement, feeding rate, and the head of the bed position on Table 4. Subjects varied according 
to day of mechanical ventilation, tube type, cuff pressure, tube feeding location and the head of 
the bed positioning. Additionally, time one (T1) and time two (T2) are shown which record the 
detection (+) or absence of detection (-) of amylase or pepsin in oropharyngeal or tracheal 
secretion samples. T1 indicates the result from the first suctioning event, and T2 represents the 
result for the second suctioning event. Oropharyngeal and tracheal suctioning events were paired 
throughout the study. 
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Table 4: Results and Description by Subject 













Oral Trach Oral Trach 

























 35 + + + - + + + + 9 24 NG stomach 50 30 
39 + + + + - + + + 10 28 OG stomach 0 30 








31 + + - - - - - - 1 26 DH stomach 45 15 
32 + + - + - - - - 15 22 DH stomach 40 20 
33 + + + + + + - - 1 24 DH postpyloric 55 90 
34 + + - - + + + + 7 24 DH postpyloric 40 30 
36 + + - - + + + + 11 24 OG stomach 50 30 
37 + + + + + + + + 10 24 OG stomach 65 30 
38 + + - - + + + + 11 24 DH postpyloric 60 30 
41 + + - - + + + - 8 22 No Tube Feed Placement 30 
Notes: + = presence of amylase or pepsin (any); - = no amylase or pepsin detected (none) 
T1 = time one, first suctioning event of the study; T2 = time two, second suctioning event of the study 
Oral = suctioned oropharynx specimen; Trach = suctioned tracheal aspirate specimen 
Day ETT/MV = endotracheal intubation and mechanical ventilation day 
Cuff press = endotracheal cuff pressure in cm H2O.  
DH = Dobbhoff, NG = Nasogastric, and OG = Orogastric.  
Tube feed rate in mL/hour. 
HOB = head of the bed positioning in degrees.  
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CHAPTER: 5: DISCUSSION 
Hypothesis 
 The hypothesis of this study is that there will be a difference in the incidence of pepsin 
and amylase in the oral and tracheal aspirate by endotracheal tube types. It is anticipated that due 
to the subglottic suctioning feature of the CSS-ETT, a reduced incidence of pepsin and amylase 
will be recorded.  
Research Question 
 Will there be a difference in the incidence of pepsin and amylase when comparing by the 
endotracheal tube type? 
Findings 
 Five of the total study group (subjects 35, 36, 37, 38, and 39) had amylase and pepsin 
detected in both the oropharyngeal and tracheal secretions (S-ETT = 2; CSS-ETT = 3). Two 
subjects (31 and 41) had only amylase detected in the oropharyngeal secretions, none detected in 
the tracheal aspirates, and no pepsin detected in either location (CSS-ETT = 2). Comparing T1 
and T2 differences in the subject data revealed that one S-ETT subject (35) had amylase detected 
in tracheal aspirate in T1 but not in T2. CSS-ETT subject 32 had no amylase detected in T!, but 
it was present in T2. S-ETT subject 39 did not have pepsin detected in the oropharyngeal sample 
in T1, but in T2, there was pepsin detected in the oropharyngeal secretion sample. In CSS-ETT 
subject 41, the T1 tracheal aspirate sample had pepsin detected that was not detected in the T2 
sample. All other subject oropharyngeal and tracheal aspirate samples that were detected or not 
detected in T1 were the same status in T2. 
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Although differences were noted, there is no statistical significance. In the S-ETT group, 
pepsin was detected in the oral secretions of 66.7% of the subjects (n = 2) while pepsin was also 
detected in the tracheal aspirates of 66.7% of the subjects (n = 2). In the CSS-ETT group, pepsin 
in oral secretions was detected in 50.0% of the subjects (n = 4) while pepsin was detected in the 
tracheal aspirate of 50.0% of the subjects (n = 4). Comparing the S-ETT and the CSS-ETT 
pepsin findings, it is apparent that a smaller percentage of the CSS-ETT subjects experienced 
tracheal aspiration of pepsin. In the S-ETT group, oral and tracheal pepsin was detected in an 
equal number of subjects (n = 2). 
 Salivary amylase was detected in the oral sample 100% of both groups’ subjects. This is 
an expected finding as salivary amylase is endogenous to the oropharyngeal region. All tracheal 
samples from the subjects in the S-ETT group (n = 3) had salivary amylase detected in the 
tracheal aspirate. In the CSS-ETT group, detection of salivary amylase in the subjects’ tracheal 
aspirate sample decreased (n = 5) compared to the oral salivary amylase detected (n = 8). While 
the amylase tracheal aspirate comparison between tube types is not statistically significant, it 
could be clinically significant. Fewer subjects with the CSS-ETT had amylase detected in their 
tracheal aspirate samples than in their oropharyngeal samples (62.5%, n = 5 versus 100%, n = 8). 
This can be compared to the entire S-ETT group which had amylase detected in the 
oropharyngeal and tracheal aspirate samples (100%, n = 3). This comparison remains outside 
statistical significance (p = 0.214), however, it may be clinically significant. 
 The dorsal, subglottic suctioning port of the CSS ETT may have demonstrated its 
effectiveness in this study. Fewer CSS-ETT subjects had tracheal aspirate biomarkers than 
oropharyngeal biomarkers. The absence of statistical significance is likely attributable to the to 
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the small sample size. Microaspiration has been estimated to occur in almost 90% of 
mechanically ventilated patients. Endotracheal tube cuffs do not form a perfect seal. Pooled 
secretions tend to leak through the folds of the cuff. The utilization of an endotracheal tube 
featuring an additional dorsal, subglottic suctioning tube removing the above the cuff, pooled 
secretions has shown substantial promise in reducing VAP rates (Nseir, 2011). Several meta-
analyses have found reduced VAP rates of up to near 50% with use of the CSS-ETT (Dezfulian 
et al., 2005; Leasure et al., 2012; Muscedere et al., 2011; Wang et al., 2012). The literature 
review confirms that there is a distinct difference in the rate of VAP between the standard versus 
subglottic suctioning groups. Consistently, there was about a 50% decrease in the incidence. 
Furthermore, the cost of the subglottic tubes is offset by the finding that of every 100 patients 
intubated with a subglottic suctioning endotracheal tube, 11 cases of VAP are avoided 
(Lacherade et al., 2010). 
 The biomarkers pepsin and amylase were detected in the tracheal aspirate of fewer 
subjects intubated with the CSS-ETT than with the S-ETT. It may be that the reduction in 
number of subjects’ aspirates positive for pepsin and salivary amylase shown in this study may 
be one reason for the lower levels of VAP reported by researchers. The findings of this 
secondary study demonstrate differences, but are not statistically significant. The incidence of 
pepsin and salivary amylase by comparison of tube types, but there may be clinical significance.  
 Limitations of the Study 
 This study has recognized limitations. Time constraints, a limited number of participants, 
a single center study, and the absence of a randomized control group are all identified 
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limitations. The small number of participants is judged to be the most significant identified 
limitation. 
Time Constraints 
 Since the primary suctioning cues study had been operational for several months by the 
time the secondary study was instigated, this study was limited by a three month primary study 
end point time frame. 
Limited Number of Participants 
 The 11 subjects at one ICU comprised the entire group. It can be argued that the study’s 
statistical significance may have been limited by the small number of participants. However, the 
study was designed for a small number group.  
Absence of a Randomized Control Group 
 This study is descriptive in nature and describes the results from the patients intubated 
with S-ETT or CSS-ETT. There was no randomization in the selection of type of tube used 
during the patient’s stay. However, there were two groups, a standard group and a subglottic 
suctioning group.  
Implications for Further Research 
 Future, expanded research with multiple study sites could attain statistical significance. A 
larger sample size is another recommendation for future research. The study of a larger group 
may potentially reveal differences indistinguishable in this study comparing incidence of pepsin 
and salivary amylase aspiration by tube type in a group of 11 subjects. Lacherade et al. (2010) 
utilized a relatively larger sample size of 333 subjects which were then randomized to either S-
ETT or CSS-ETT intubation. The multicenter study revealed a decrease in late onset pneumonia 
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which the researchers directly relate to having a larger study group. The greater number of 
participants undergoing mechanical ventilation for longer than five days may have revealed the 
relationship (Lacherade et al., 2010).  
Clinical Implications 
 This study adds information to the body of knowledge in an effort to prevent VAP. It 
appears that the use of CSS-ETT instead of S-ETT may offer protection against secretions 
seeping into the patient’s lower airway region as indicated by reduced incidence of biomarkers in 
the CSS-ETT group compared to the S-ETT group. However, the comparison is not statistically 
significant as was discussed earlier. Even though tracheal (n = 4) versus oral 9 (n = 5) pepsin was 
detected in fewer patients, the data is not significant by tube type (p = 0.898). Salivary amylase 
was decreased from oral (n = 8) versus tracheal (n = 5) in the CSS-ETT group, but this was not 
statistically significant (p = 0.214). In the S-ETT group, pepsin tracheal aspirate (n = 2) 
incidence was equal to the oral (n = 2) incidence in suctioned secretions. The salivary amylase 
oropharyngeal and tracheal aspirate were the same, comprising the entire subgroup (n = 3). Data 
gathered from this group size (n = 11) did not permit a relationship, if any, to be observed 
between incidence of pepsin and amylase as markers of aspiration and tube type. 
 The overarching aim of the primary suctioning cues study was to improve patient 
outcomes and reduce the risk for VAP. The patients in this study were accessed hourly for 
suctioning need which is more frequently than the usual suctioning need assessment interval. 
Additionally, multiple visual (waveform patterns or visually apparent mucus), auditory (tracheal 
auscultation), and other assessment data (blood gas, decreased O2 saturation, or increased peak 
airway pressure) were implemented by the researchers as suctioning cues (Sole & Bennett, 
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2012). Perhaps, the primary study’s protocol of at least hourly assessment as well as the 
implementation of multiple clinical cues rendered tube type statistically insignificant. 
Summary 
 Researchers have studied many interventions in order to reduce the risk for VAP. Head of 
the bed positioning, hand washing, use of prophylactic antibiotic and gastric acid reducing 
medications, ventilator circuit change intervals, and providing oral care to the intubated, 
mechanically ventilated critical care patient are all part of the prevent VAP strategy (Coffin et 
al., 2008). The subglottic suctioning endotracheal tube has been recommended for use as part of 
the VAP practice alert by the AACN (2008). Based on the literature review for this study, VAP 
rates were shown to have been reduced by approximately half (Appendix A). Additionally, from 
the clinical results of this study, there was a reduction in the number of patients who had tracheal 
compared to oral suctioned pepsin and salivary amylase by tube type. However, the results were 
not significant. The intention of this study was that it would assist in demonstrating beneficial 
aspects of the endotracheal tube type selection. However, incidence of the selected biomarkers 
by tube types was not statistically significant. It could be that the other factors, suctioning cues, 
at least hourly assessment, and now standard interventions, such as head of the bed positioning, 
are more significant in this study than endotracheal tube type.  
 Although the results are not statistically significant when comparing pepsin detected in 
the oropharyngeal samples (p = 0.898) and tracheal aspirate samples (p = 0.621) by tube type, 
there may be clinical significance. In the CSS-ETT group the number of subjects that had pepsin 
oral decreased from six to four individuals with tracheal pepsin detected in their aspirate. There 
was no difference in the number of S-ETT subjects that had oral or tracheal pepsin detected (n = 
33 
 
2). Therefore, statistically speaking, any differences in the incidence of biomarkers by tube types 
in this study have a high chance of being unrelated to the tube type. 
 Potentially, future investigation with a larger population group could add the missing 
statistical significance to tube type absent in this study. A larger group may reveal a significance 
unseen at this study size (n = 11). On the other hand, perhaps, the clinical implication from this 
study is that the microaspiration prevention protocols in place in the critical care setting and the 
primary study’s clinical suctioning protocol made tube type selection insignificant. 
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Appendix A: Literature Review Table 
 
Author, Year Population (n) Study Design Intervention Details Outcome Measures Results/Key Findings 
Bouza et al., 2008 714 Prospective, 
randomized, 
comparative study 
S-ETT vs. CSS-ETT Incidence of VAP, 




CASS group demonstrated lower 
rates of VAP, MV, ICU/hospital stay, 
C. diff infection, and reduced 
antibiotic consumption. 
 
The two groups experienced similar 
mortality (20 vs. 21). 
Dezfulian et al., 2005 896  Systematic, meta-
analysis of  5 RCTs 
S-ETT vs. CSS-ETT Incidence/onset  of 
VAP, 
LOS ICU, 
Days on MV, 
Mortality. 
Subglottic drainage tubes reduced 
VAP incidence by almost 50%, 
decreased early onset VAP, 
increased days to VAP onset, 
decreased MV days and ICU LOS. 
No effect on mortality. 
Junega et al., 2011 311  Retrospective records 
review 
S-ETT vs. CSS-ETT Incidence of VAP/1000 
ventilator days, 
Episodes of VAP, days 
on MV, length of stay, 
mortality.  
VAP reduced from 25 to 15.7/1000 
MV days comparing the closed 
system, intermittent subglottic 
suctioning group to the control. 
No other results were deemed 
significant. 
Lacherade et al., 2010 333 Clinical randomized 
controlled trial 
S-ETT vs. CSS-ETT Overall incidence of 
VAP, early and late 
onset VAP, duration of 
MV, hospital mortality 
Patients with the subglottic secretion 
drainage had lower rates of VAP than 
the standard group (14.8% vs. 
25.6%), lower rates of early onset 
(1.2% vs. 6.1%) and late onset of 
VAP (18.6% vs. 33.0%). 
Results were not significant for 




Author, Year Population (n) Study Design Intervention Details Outcome Measures Results/Key Findings 
Leasure et al., 2012 1,829 Systematic, meta-
analysis of 13 RCTs 
S-ETT vs. CSS-ETT Incidence of VAP, days 
to onset of VAP, 
duration of MV, 
ICU/hospital LOS. 
CSS-ETT group demonstrated lower 
rates of VAP, MV, ICU/hospital stay, 
C. diff infection, and reduced 
antibiotic consumption. 
The two groups experienced similar 
mortality (20 vs. 21). 
Lorente et al., 2007 280  Clinical randomized 
controlled trial  
S-ETT vs. CSS-ETT Incidence/onset of VAP VAP rates were 22.1% of S-ETT vs. 
7.9% in CS-ETT, rates of early onset 
and late onset VAP were also lower in 
the CSS-ETT group 
Muscedere et al., 2011 2,442 Systematic, meta-
analysis of  13 RCTs 






CSS-ETT group experienced 50% 
reduction in VAP vs. S-ETT group, 
similar VAP reduction, decreased 
ICU, MV, onset of days to VAP, no 
effect on mortality or hospital LOS. 
Smulders et al., 2002 150 Clinical randomized 
controlled trial 
S-ETT vs. CSS-ETT Incidence of VAP, 
duration of MV, 
ICU/hospital LOS, 
mortality 
VAP rates were 16% of S-ETT vs. 
4% in CSS-ETT group. 
The other outcome measures were not 
significant. 
Speroni et al., 2011 154 Retrospective records 
review 
S-ETT vs. CSS-ETT Diagnosis of VAP 
Days on MV 
Length of stay 
Cost of stay 
 
One case of VAP in the S-ETT group, 
none in the CSS-ETT group. 
ICU days and MV days greater for 
CSS-ETT group. 
Mean hospital charges $103,600 (S-




Author, Year Population (n) Study Design Intervention Details Outcome Measures Results/Key Findings 
Wang et al., 2012 2,213 Systematic, meta-
analysis of 13 RCTs 
S-ETT vs. CSS-ETT Incidence/onset of 
VAP, ICU/hospital 
LOS, MV duration, 
mortality. 
Patients intubated with CSS-ETT had 
a decreased incidence of VAP, 
decreased incidence of early onset 
VAP, decreased MV days, and 
increased time to onset of VAP. No 
significant differences between tube 
type for late onset VAP, overall 
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